Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?
Medicinal Research Reviews · 2026-07 · 46 (4) · 1111-1151
DOI: 10.1002/med.70042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 07.04.2026. Verfasst von Lara R S Fonseca und 6 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Covilhã, Portugal. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Microbiota, Urinary Tract. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 364 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liga Portuguesa Contra a Cancro (LPCC) Bolsa LPCC/Gillette-Cancro da Próstata, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to cancer diagnosis and therapy. The bacteriome is the component of the microbiome that is most metabolically active and influenceable by internal and external factors, which is pivotal in the development of cancer. Initial studies exploring the link between the microbiome and PCa focused primarily on the gut bacteriome, which has been implicated in the onset and progression of the disease, as well as in resistance to therapy. Further research has demonstrated that the urologic bacteriome also plays a crucial role in the development of PCa, serving as an important factor for diagnosis and treatment. This review synthesizes current knowledge concerning the significance of the urologic bacteriome in PCa onset, progression, diagnosis/prognosis, and therapy. It also explores the impact of the bacterial metabolome in PCa, emphasizing the importance of this undervalued dimension of the bacteriome. Overall, the review provides a comprehensive analysis of how bacteria and their bioactive metabolites contribute to PCa, highlighting their clinical and therapeutic relevance. It also identifies the existing knowledge gaps, paving the way for the development of new approaches that could enhance PCa diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Covilhã, Portugal.
- RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Instituto Português de Oncologia de Coimbra Francisco Gentil, Coimbra, Portugal.
- Institute of Reproductive Genetics, Centre of Medical Genetics, University of Münster, Münster, Germany.
- Labfit - HPRD Health Products Research and Development, Lda, Covilhã, Portugal.
ORCID-Profile: Bruno J Pereira, Sandra Laurentino, Sílvia Socorro
Förderung
- Liga Portuguesa Contra a Cancro (LPCC) Bolsa LPCC/Gillette-Cancro da Próstata
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Fonseca, L. R. S., Feijó, M., Vaz, C. V., Pereira, B. J., Laurentino, S., Palmeira-de-Oliveira, A., & Socorro, S. (2026). Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?. Medicinal Research Reviews, 46(4), 1111-1151. https://doi.org/10.1002/med.70042
Vancouver
Fonseca LRS, Feijó M, Vaz CV, Pereira BJ, Laurentino S, Palmeira-de-Oliveira A, et al. Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?. Medicinal Research Reviews. 2026;46(4):1111-1151. doi:10.1002/med.70042
BibTeX
@article{Fonseca2026,
author = {Fonseca, Lara R S and Feijó, Mariana and Vaz, Cátia V and Pereira, Bruno J and Laurentino, Sandra and Palmeira-de-Oliveira, Ana and Socorro, Sílvia},
title = {Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {4},
pages = {1111--1151},
doi = {10.1002/med.70042}
}
EUVIMED